secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dyne Therapeutics, Inc. (DYN)
CIK:        0001818794
Form:       8-K
Filed at:   2024-01-04T23:59:59+00:00
Accession:  0001193125-24-002542
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Dyne Therapeutics suspends ATM offering; had raised $92.2M from prior sales
---------------------------------------------------------------------------

- Company notified Jefferies it suspended and terminated the ATM prospectus dated Nov 17, 2021.
- Sales agreement remains in effect; no further sales until a new prospectus is filed.
- As of Jan 4, 2024, sold 7,943,148 shares for aggregate gross proceeds of $92.2 million.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818794/000119312524002542/0001193125-24-002542-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818794/000119312524002542/d687857d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-002542

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer